Hong Kong Shue Yan University Launching Two New Commerce Undergraduate Programmes
Hong Kong Shue Yan University has launched two new commerce undergraduate programmes, namely
National Astronomy Meeting 2025 – exploring Durham’s rich astronomical research
Almost a thousand of the world’s top space scientists will visit Durham University next week (7 to 11 July) as we host the UK’s National Astronomy Meeting (NAM) 2025.
Bird prediction tool takes flight in Eureka prizes
The team behind a powerful tool that helps farmers identify management actions that could support threatened birds on their properties is in the running for Australia's top science prizes.
Warwick Ancient Drama Festival returns with Aeschylus’ Agamemnon
The 11th annual Warwick Ancient Drama Festival returns to The University of Warwick on 30 and 31 January presenting Aeschylus’ Agamemnon.
World first: Monash University researchers identify potential cause and treatment for obesity and insulin...
Monash University researchers have shown for the first time that mesenteric (gut) lymphatic dysfunction is a potential cause of and therapeutic target for obesity and insulin resistance.
Finger-prick test could screen for early Alzheimer’s
GPs could soon be able to screen their patients for Alzheimer’s Disease (AD) using a simple handheld device developed by Monash engineers.
New tests for designer drugs could help save lives
UTS researchers are developing new drug tests to detect illicit synthetic drugs.
Clinical trials without humans – why computer simulations could make drugs a lot cheaper
This article by Dr Wahbi K El-Bouri from the University’s Department of Cardiovascular and Metabolic Medicine, was first published for The Conversation...
The 3rd NEWstories Conference
The aim of the conference is to bring together both undergraduate and postgraduate literary scholars so that they can share their academic interests and the results of their research.
Antibody therapies against Covid-19 for most vulnerable patients work, new analysis finds
The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective, a new study has found.
